<DOC>
	<DOCNO>NCT00856271</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety olmesartan medoxomil compare losartan potassium patient mild moderate essential hypertension .</brief_summary>
	<brief_title>Olmesartan Medoxomil Versus Losartan Potassium Patients With Mild Moderate Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>mild moderate essential hypertension ( mean seat diastolic blood pressure â‰¥ 95 mmHg &lt; 110 mmHg , mean seat systolic blood pressure &lt; 180 mmHg ) able give write informed consent know suspected secondary hypertension history chronic hepatic disease obstructive hypertrophic cardiomyopathy/clinically significant valvular heart disease cardiac arrhythmia unstable angina pectoris congestive heart insufficiency ( New York Heart Association classification IIIIV ) bilateral renal artery stenosis isolate renal artery stenosis post renal transplantation history acute myocardial infarction/percutaneous transluminal coronary angioplasty heart surgery within three month enrollment retina bleeding/effusion insulin dependent diabetes mellitus uncontrolled noninsulin dependent diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>